President-elect Trump said it was very “unlikely” that the U.S. Food and Drug Administration (FDA) would revoke access to the abortion pill in his interview with Time as the “Person of the Year.”

“Look, I’ve stated it very clearly and I just stated it again very clearly. I think it would be highly unlikely,” he said. 

“I can’t imagine, but with, you know, we’re looking at everything, but highly unlikely.”

Trump’s comments echo his rhetoric from a recent sit-down interview on NBC’s “Meet the Press,” where he said he didn’t think access to abortion pills would change.

He said the pill known as mifepristone, sold under the brand name Mifeprex, was understudied.

“There will be a time in the future where people are going to know everything about subjects like that, which are very complex subjects for people, because you have other people that, you know, they feel strongly both ways, really strongly both ways, and those are the things that are dividing up the country,” the incoming president told Time.

“But you know my stand from a very long, hard thing, and I think it’s highly unlikely that I ever change that.”

Anti-abortion groups have pushed for federal reforms after the FDA removed requirements for patients to see a physician before obtaining the pill in 2021. 

In March, the Supreme Court dismissed a case that sought to take the drug off the market citing patients’ rate of complications.

The ruling triggered responses from anti-abortion groups and became a crucial topic during the 2024 presidential election.

Trump did not make clear whether or not he would encourage the FDA to reinstate in-person requirements for the abortion pill.